- Home
- RCON vs CDTX Comparison
RCON vs CDTX Comparison
Compare RCON & CDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCON
- CDTX
- Stock Information
- Founded
- RCON 2007
- CDTX 2012
- Country
- RCON China
- CDTX United States
- Employees
- RCON N/A
- CDTX N/A
- Industry
- RCON Oilfield Services/Equipment
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RCON Energy
- CDTX Health Care
- Exchange
- RCON Nasdaq
- CDTX Nasdaq
- Market Cap
- RCON 82.6M
- CDTX 79.3M
- IPO Year
- RCON 2009
- CDTX 2015
- Fundamental
- Price
- RCON $2.02
- CDTX $14.37
- Analyst Decision
- RCON
- CDTX Strong Buy
- Analyst Count
- RCON 0
- CDTX 5
- Target Price
- RCON N/A
- CDTX $30.50
- AVG Volume (30 Days)
- RCON 17.0K
- CDTX 21.1K
- Earning Date
- RCON 06-28-2024
- CDTX 11-07-2024
- Dividend Yield
- RCON N/A
- CDTX N/A
- EPS Growth
- RCON N/A
- CDTX N/A
- EPS
- RCON N/A
- CDTX N/A
- Revenue
- RCON $9,475,055.00
- CDTX $44,653,000.00
- Revenue This Year
- RCON N/A
- CDTX N/A
- Revenue Next Year
- RCON $15.18
- CDTX N/A
- P/E Ratio
- RCON N/A
- CDTX N/A
- Revenue Growth
- RCON 2.59
- CDTX 19.60
- 52 Week Low
- RCON $1.26
- CDTX $10.00
- 52 Week High
- RCON $5.58
- CDTX $24.40
- Technical
- Relative Strength Index (RSI)
- RCON 31.70
- CDTX 72.85
- Support Level
- RCON $2.40
- CDTX $12.89
- Resistance Level
- RCON $2.80
- CDTX $13.78
- Average True Range (ATR)
- RCON 0.29
- CDTX 0.70
- MACD
- RCON -0.06
- CDTX 0.13
- Stochastic Oscillator
- RCON 0.00
- CDTX 75.31
About RCON Recon Technology Ltd.
Recon Technology Ltd is an oilfield service company. The company is engaged in the sale of oilfield automation products, equipment for oil and gas production and transportation, and engineering services. It has four reportable operating segments: Automation Product and Software, Equipment and Accessories, Platform outsourcing services, and Oilfield Environmental Protection. Majority of the firm's revenue comes from the Automation Product and Software segment.
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.